U.S. Food and Drug Administration
Protecting and Promoting Your Health
Small Business Assistance
Center for Drug Evaluation and Research
Engaging with the FDA During New Drug Development
Formal Meetings with FDA
|
Question: Is the post-action meeting requested 3 months or more AFTER an action considered a new Type B meeting? |
|
Answer:
Yes. |
USER INSTRUCTIONS:
Click NEXT to continue.
Page 13 of 38
